Sign-on letter RE: 2025-2030 Dietary Guidelines for Americans to HHS and USDA

As over 200 members of the medical and research community, we are deeply concerned that the advice in the recently released 2025–2030 Dietary Guidelines for Americans is, at best, confusing, and, at worst, harmful to public health. By rejecting the majority of evidence-based recommendations from the 2025 Dietary Guidelines Advisory Committee, we believe the document falls short of its legal mandate — from the National Nutrition Monitoring and Related Research Act of 1990 (Public Law 101-445) — for the Guidelines to be based on “the preponderance of the scientific and medical knowledge which is current at the time the report is prepared." This DGA process also does not comply with President Trump’s May 2025 Executive Order No. 14303, “Restoring Gold Standard Science.”

Health and science professionals question scientific basis of 2025–2030 Dietary Guidelines for Americans

Which plant-based milks are healthy and higher in protein?

Here's which plant-based milks from major brands are higher in protein and fortified with enough calcium, vitamin D, and vitamin B-12 to match dairy milk.

Current and past partners

See what CSPI's partners have accomplished in their communities.

Introducing CSPI’s Food Policy Catalyst partners

CSPI's Food Policy Catalyst partners include 21 organizations spanning 15 states who are activating change from their local neighborhoods to the national level.

The USDA’s Food Security Survey is irreplaceable

Losing USDA's HFSSM leaves policymakers, researchers, and advocates without access to the only comprehensive tool for assessing national food security trends.

What kind of running or walking shoes are best?

Trends in running shoes are constantly shifting: minimalist, maximalist, and so on. But what you should wear depends on your needs, not what’s in vogue.

Letter to former FDA Commissioner Califf urging development of laboratory-developed test (LDT) regulations

Letter to Office of Management and Budget supporting FDA regulation of laboratory-developed tests (LDTs)

Comment on FDA’s Proposed Rule on Laboratory-Developed Tests (LDTs)

Comment on Proposed Rule re: Medical Devices; Laboratory Developed Tests (Docket No. FDA-2023-N-2177)